Falcon Point Capital’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,118
Closed -$140K 110
2019
Q3
$140K Buy
25,118
+417
+2% +$2.32K 0.08% 101
2019
Q2
$148K Buy
24,701
+280
+1% +$1.68K 0.08% 100
2019
Q1
$221K Buy
24,421
+580
+2% +$5.25K 0.12% 94
2018
Q4
$198K Sell
23,841
-4,931
-17% -$41K 0.12% 93
2018
Q3
$397K Sell
28,772
-5,197
-15% -$71.7K 0.09% 81
2018
Q2
$270K Buy
+33,969
New +$270K 0.05% 105